Indian Adviser Urges More Attention to Gender-Specific Drugs
This article was originally published in PharmAsia News
Executive Summary
An adviser at India's National Institute of Immunology says the country should place more emphasis on the differences between drugs for males and those for females. N.K. Ganguly said the country currently produces drugs focused on the needs of men while ignoring the needs of women even though the needs of each are quite different. India has developed about 30 life-saving drugs in the past few years, Ganguly said, but many are neither compatible nor affordable for Indian women. He urged drug makers to consider the changing needs of the country. (Click here for more